"Leukemia, Myeloid, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Concept/Terms
Leukemia, Myeloid, Acute- Leukemia, Myeloid, Acute
- ANLL
- Leukemia, Myeloblastic, Acute
- Leukemia, Myelocytic, Acute
- Leukemia, Myelogenous, Acute
- Nonlymphocytic Leukemia, Acute
- Acute Nonlymphocytic Leukemia
- Acute Nonlymphocytic Leukemias
- Leukemia, Acute Nonlymphocytic
- Leukemias, Acute Nonlymphocytic
- Nonlymphocytic Leukemias, Acute
- Leukemia, Nonlymphocytic, Acute
- Myeloblastic Leukemia, Acute
- Acute Myeloblastic Leukemia
- Acute Myeloblastic Leukemias
- Leukemia, Acute Myeloblastic
- Leukemias, Acute Myeloblastic
- Myeloblastic Leukemias, Acute
- Myelocytic Leukemia, Acute
- Acute Myelocytic Leukemia
- Acute Myelocytic Leukemias
- Leukemia, Acute Myelocytic
- Leukemias, Acute Myelocytic
- Myelocytic Leukemias, Acute
- Myelogenous Leukemia, Acute
- Acute Myelogenous Leukemia
- Acute Myelogenous Leukemias
- Leukemia, Acute Myelogenous
- Leukemias, Acute Myelogenous
- Myelogenous Leukemias, Acute
- Myeloid Leukemia, Acute
- Nonlymphoblastic Leukemia, Acute
- Acute Nonlymphoblastic Leukemia
- Acute Nonlymphoblastic Leukemias
- Leukemia, Acute Nonlymphoblastic
- Leukemias, Acute Nonlymphoblastic
- Nonlymphoblastic Leukemias, Acute
- Acute Myeloid Leukemia
- Acute Myeloid Leukemias
- Leukemia, Acute Myeloid
- Leukemias, Acute Myeloid
- Myeloid Leukemias, Acute
- Leukemia, Nonlymphoblastic, Acute
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Acute".
- Leukemia, Myeloid, Acute
- Leukemia, Basophilic, Acute
- Leukemia, Eosinophilic, Acute
- Leukemia, Erythroblastic, Acute
- Leukemia, Mast-Cell
- Leukemia, Megakaryoblastic, Acute
- Leukemia, Monocytic, Acute
- Leukemia, Promyelocytic, Acute
This graph shows the total number of publications written about "Leukemia, Myeloid, Acute" by people in Harvard Catalyst Profiles by year, and whether "Leukemia, Myeloid, Acute" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 1 | 3 |
| 1994 | 8 | 3 | 11 |
| 1995 | 8 | 2 | 10 |
| 1996 | 5 | 1 | 6 |
| 1997 | 7 | 3 | 10 |
| 1998 | 5 | 0 | 5 |
| 1999 | 4 | 1 | 5 |
| 2000 | 7 | 1 | 8 |
| 2001 | 9 | 2 | 11 |
| 2002 | 11 | 2 | 13 |
| 2003 | 15 | 1 | 16 |
| 2004 | 11 | 3 | 14 |
| 2005 | 10 | 2 | 12 |
| 2006 | 15 | 2 | 17 |
| 2007 | 20 | 4 | 24 |
| 2008 | 26 | 12 | 38 |
| 2009 | 35 | 6 | 41 |
| 2010 | 59 | 9 | 68 |
| 2011 | 51 | 7 | 58 |
| 2012 | 67 | 7 | 74 |
| 2013 | 66 | 5 | 71 |
| 2014 | 74 | 8 | 82 |
| 2015 | 71 | 14 | 85 |
| 2016 | 102 | 18 | 120 |
| 2017 | 108 | 13 | 121 |
| 2018 | 113 | 13 | 126 |
| 2019 | 106 | 6 | 112 |
| 2020 | 114 | 2 | 116 |
| 2021 | 128 | 6 | 134 |
| 2022 | 128 | 1 | 129 |
| 2023 | 6 | 0 | 6 |
Below are the most recent publications written about "Leukemia, Myeloid, Acute" by people in Profiles.
-
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia. Cancer Discov. 2023 Mar 01; 13(3):746-765.
-
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clin Cancer Res. 2023 Mar 01; 29(5):878-887.
-
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023 03; 98(3):502-526.
-
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial. Blood. 2023 01 12; 141(2):156-167.
-
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO Precis Oncol. 2023 Jan; 7:e2200400.
-
The International Consensus Classification of myelodysplastic syndromes and related entities. Virchows Arch. 2023 Jan; 482(1):39-51.
-
An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. 2023 01; 4(1):27-42.
-
Moving toward more molecular classifications of myelodysplastic syndrome and acute myeloid leukemia. Am J Hematol. 2023 03; 98(3):377-378.
-
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia. Curr Opin Hematol. 2023 03 01; 30(2):38-44.
-
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. Cancer Cell. 2023 01 09; 41(1):164-180.e8.